Great idea but I can't see men choosing to wear this, and then having to use it from the phone first? I think it would be equally embarrassing for men to wear it. Can I hear your thoughts?

Our initial target market are couples in committed relationships who wish to delay ejaculation. Our research suggests a strong interest in men wanting to try a wearable patch. In a recent survey of 40 men, 40/40 indicated they were very interested or extremely interested when asked the question "How interested are you in trying the Mor Time wearable patch?" We have also performed comfort and fit studies of the patch with positive ratings. Having a mobile app available via a smartphone gives t...

I have a few more questions please if you could respond, I have read form C, Who owns the patents? What is the 13.5% compensation used for exactly? Will you provide a liquidity event to convert preferred shares to common? Are you offering participating liquidation preferences?...

Morari Medical owns all current patent filings. The 13.5% of compensation will be used to compensate CEO, finance, commercialization, operations and R&D leaders. There is no liquidity event that mandates the conversion of preferred shares to common. However, upon a “Deemed Liquidation Event” (as defined in our current charter), holders of Preferred Stock will be paid the greater of the Original Issue Price per share of preferred stock OR such amount per share as would be payable if all sh...

How would you rate your competition with such as Virility Medical and others?

There have been multiple attempts to treat premature ejaculation (PE) through a variety of methods to include physiological/behavioral counseling, drug treatment, topical local anesthetics, cryoablation and radio frequency. To date there is no chemical-free wearable product option available to consumers. We are aware of Virility Medical and look forward to another company helping to drive awareness of PE. We believe we will have an overall superior user experience.

Virility already have the same product as yours? Why is yours unique?

We are aware of Virility Medical and look forward to another company helping to drive awareness of PE. We believe we will have an overall superior user experience.

What is the regulatory pathway? Have u confirmed that it would be a class I ? Will be it allowed to be a 510k? Thanks

Our patch would be considered a class II device and would be considered a 510k submission. We had a very positive pre-sub meeting with the FDA earlier this year. We have a clear path to FDA clearance and know what testing and data is needed for submission.

Morari, Inc.

Climax Control Patch for a MOR Intimate Experience

morarimedical.com

Maple Grove, MN

Consumer Goods B2C Health & Fitness Home Tech

What Investors Say

LEAD INVESTOR

Invested $100,000 this round

Back in the late 1990's I was honing my early communication skills at Pfizer, with our launch of Viagra. So I'm deeply aware of both the challenges and the massive opportunities associated with true innovation in the sexual health area. Morari, Inc., CEO Jeff Bennett and his skilled team are perfectly poised to bring Morari's climax control patch, Mor, to a large market that will benefit immensely from the technology. Consider joining me in what may possibly be the last investment opportunity with Morari, before approval and launch.

What People Say

Morari, Inc.

Quick facts

Team profiles

Featured investor profiles

$305,896

What Investors Say